Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537855) titled 'Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction: A Randomized Crossover Pilot Study' on April 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Northwestern University
Condition:
Erectile Dysfunction
Intervention:
Drug: IncobotulinumtoxinA (100 Units)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: June 2026
Target Sample Size: 30
To know more, visi...